ResTORbio Competitors and Similar CompaniesClear all
ResTORbio's competitors and similar companies include Protalex and Zhaoke Ophthalmology Pharmaceutical.
 ResTORbio ResTORbio is a company, developing medicines to treat aging-related diseases and conditions. |  Protalex Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases. |  Zhaoke Ophthalmology Pharmaceutical Zhaoke Ophthalmology Pharmaceutical (兆科药业（合肥）有限公司) is a pharmaceutical company and an indirect subsidiary of Lee's Pharmaceutical Holdings Ltd. | |
Founding Date | Founding Date 2016 | Founding Date 1999 | Founding Date 1994 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Boston, US HQ | Locations Florham Park, US HQ | Locations HK HQ |
Employees | Employees 7 | Employees 233% decrease | Employees N/A |
Valuation ($) | Valuation ($) 11.9 m | Valuation ($) 615.2 k | Valuation ($) N/A |
Financial | |||
Net income | Net income ($62m) (FY, 2021) | Net income ($5m) (FY, 2018) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 65m | Total funding raised N/A | Total funding raised $ 145m |
For sources of this data, please see the company profile
View Company Profiles
Protalex
HQ
Florham Park, US
Employees
2↓ 33% decrease
Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases.
View companyZhaoke Ophthalmology Pharmaceutical
HQ
HK
Zhaoke Ophthalmology Pharmaceutical (兆科药业（合肥）有限公司) is a pharmaceutical company and an indirect subsidiary of Lee's Pharmaceutical Holdings Ltd.
View company